Molecular changes in genes that encode for epigenetic modifiers (SMARCA2, CREBBP, KDM6A), proliferation regulators (EGFR, PIK3CA, KRAS, AXL, MET, MYC) and tumor suppressors (ATM, CDKN2A, TP53) have also been noted in ACC patients [11, 18, 21]. The gene discussed is MYC; the disease is adrenal cortex carcinoma.